Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Milestone Pharmaceuticals stock
Learn how to easily invest in Milestone Pharmaceuticals stock.
Milestone Pharmaceuticals Inc is a biotechnology business based in the US. Milestone Pharmaceuticals shares (MIST) are listed on the NASDAQ and all prices are listed in US Dollars. Milestone Pharmaceuticals employs 29 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Milestone Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MIST – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Milestone Pharmaceuticals stock price (NASDAQ: MIST)Use our graph to track the performance of MIST stocks over time.
Milestone Pharmaceuticals shares at a glance
|Latest market close||$9.00|
|52-week range||$3.98 - $9.85|
|50-day moving average||$7.73|
|200-day moving average||$6.60|
|Wall St. target price||$14.40|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.05|
Buy Milestone Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Milestone Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Milestone Pharmaceuticals price performance over time
|1 week (2022-09-23)||13.78%|
|1 month (2022-09-01)||2.39%|
|3 months (2022-07-01)||53.58%|
|6 months (2022-03-31)||40.19%|
|1 year (2021-10-01)||59.57%|
|2 years (2020-10-01)||26.76%|
|3 years (2019-10-01)||18.22|
|5 years (2017-09-27)||N/A|
Milestone Pharmaceuticals financials
|Gross profit TTM||$15 million|
|Return on assets TTM||-32.75%|
|Return on equity TTM||-54.6%|
|Market capitalisation||$237.4 million|
TTM: trailing 12 months
Milestone Pharmaceuticals share dividends
We're not expecting Milestone Pharmaceuticals to pay a dividend over the next 12 months.
Milestone Pharmaceuticals share price volatility
Over the last 12 months, Milestone Pharmaceuticals's shares have ranged in value from as little as $3.98 up to $9.847. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Milestone Pharmaceuticals's is 2.6518. This would suggest that Milestone Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Milestone Pharmaceuticals overview
Milestone Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada. .
Milestone Pharmaceuticals in the news
Oppenheimer Says Biotech Stocks Look a Bit Brighter Right Now; Here Are 2 Names to Consider
Milestone Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Frequently asked questionsWhat percentage of Milestone Pharmaceuticals is owned by insiders or institutions?
Currently 1.207% of Milestone Pharmaceuticals shares are held by insiders and 83.027% by institutions. How many people work for Milestone Pharmaceuticals?
Latest data suggests 29 work at Milestone Pharmaceuticals. When does the fiscal year end for Milestone Pharmaceuticals?
Milestone Pharmaceuticals's fiscal year ends in December. Where is Milestone Pharmaceuticals based?
Milestone Pharmaceuticals's address is: 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6 What is Milestone Pharmaceuticals's ISIN number?
Milestone Pharmaceuticals's international securities identification number is: CA59935V1076 What is Milestone Pharmaceuticals's CUSIP number?
Milestone Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 59935V107
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert